- Report
- March 2024
- 27 Pages
Brazil
From €825EUR$926USD£715GBP
- Report
- March 2024
- 137 Pages
Brazil
From €2200EUR$2,469USD£1,908GBP
- Report
- June 2023
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- September 2022
- 15 Pages
Indonesia
From €825EUR$926USD£715GBP
- Report
- September 2021
- 23 Pages
Russia
From €825EUR$926USD£715GBP
- Report
- September 2021
- 16 Pages
Egypt
From €825EUR$926USD£715GBP
- Report
- September 2022
- 310 Pages
Global
From €3665EUR$3,840USD£3,071GBP
- Report
- October 2022
- 290 Pages
Global
From €3407EUR$3,570USD£2,855GBP
- Report
- August 2022
- 278 Pages
Global
From €3407EUR$3,570USD£2,855GBP
- Report
- July 2022
- 300 Pages
Global
From €3407EUR$3,570USD£2,855GBP
- Report
- April 2022
- 230 Pages
Global
From €3298EUR$3,456USD£2,764GBP
- Report
- October 2021
- 283 Pages
Global
From €3298EUR$3,456USD£2,764GBP
- Report
- May 2021
- 289 Pages
Global
From €3543EUR$3,712USD£2,968GBP

The Nicotine Replacement Therapy (NRT) market is a subset of the Over the Counter (OTC) Drugs market. NRT products are designed to help people quit smoking by providing a safe and effective way to reduce nicotine cravings. These products come in a variety of forms, including patches, gum, lozenges, inhalers, and sprays. NRT products are available without a prescription and are often used in combination with other smoking cessation methods, such as counseling and support groups.
NRT products are widely available in pharmacies, supermarkets, and other retail outlets. They are also available online, making them accessible to a wider range of consumers. NRT products are generally considered safe and effective, and they are often recommended by healthcare professionals as part of a comprehensive smoking cessation plan.
Some companies in the NRT market include GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Perrigo. Show Less Read more